PD-L1 and PD-L2 Expression in Cervical Cancer: Regulation and Biomarker Potential

PD-1/PD-L1 immune checkpoint inhibitors show potential for cervical cancer treatment. However, low response rates suggest that patient selection based on PD-L1 protein expression is not optimal. Here, we evaluated different PD-L1 detection methods and studied transcriptional regulation of PD-L1/PD-L...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Front Immunol
Glavni autori: Rotman, Jossie, den Otter, Leontine A. S., Bleeker, Maaike C. G., Samuels, Sanne S., Heeren, A. Marijne, Roemer, Margaretha G. M., Kenter, Gemma G., Zijlmans, Henry J. M. A. A., van Trommel, Nienke E., de Gruijl, Tanja D., Jordanova, Ekaterina S.
Format: Artigo
Jezik:Inglês
Izdano: Frontiers Media S.A. 2020
Teme:
Immunology
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7793653/
https://ncbi.nlm.nih.gov/pubmed/33424844
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fimmu.2020.596825
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items